Investment-grade and high-yield corporate bonds, small caps and European stocks lead the firm’s list.
Investment-grade and high-yield corporate bonds, small caps and European stocks lead the firm’s list.
Sun Pharma-owned pharmaceutical company agrees to pay $36 million due to allegations it fixed prices and misled investors.
The firm allegedly misled investors about its compliance and oversight of transactions, including those made by defunct cryptocurrency exchange FTX.
The loans yield around 10% yearly, a big enticement to investors, and borrower demand is high, according to Turning Rock Partners.